FolioLanternBeta
TXG10x Genomics, Inc.

Serge Saxonov

Chief Executive Officer, Director at 10x Genomics, Inc., as of Sep 24, 2026Sold $6.8M of stock in the past 12 months: 77% under a disclosed plan and 23% to cover taxes.

Updated Oct 16, 2026 from SEC filings · covers Oct 17, 2025 to Oct 16, 2026
172K
shares sold, past 12 months
12
days with sales
$2.0M
largest single day, Sep 22, 2026
1
company filed for

Share of stake sold and shares held at 10x Genomics, Inc. are being verified and not shown yet. Why

Selling by month

Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.

Disclosed planTo cover taxesOne dollar scale for every month; the tallest bar is labeled
OctNov 2025: $252K to cover taxesNovDecJanFeb 2026: $179K to cover taxesFebMar 2026: $656K under a disclosed planMarApr 2026: $123K under a disclosed planAprMay 2026: $709K under a disclosed planMayJun 2026: $1.0M under a disclosed planJunJulAug 2026: $668K under a disclosed planAug 2026: $1.2M to cover taxesAugSep 2026: $2.0M under a disclosed plan$2.0MSepOct

Pattern

What the filings show, past 12 months. Nothing here rates or predicts.

Roles from filings

Every company we track where this person has filed, newest filing first.

CompanyTitleFirst filingLatest filing
10x Genomics, Inc. (TXG)Chief Executive Officer, DirectorSep 11, 2019Sep 24, 2026

Recent filings

The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.

This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.